Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant Recipients

KNOW-KT Study Group

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background A higher body mass index (BMI) before kidney transplantation (KT) is associated with increased mortality and allograft loss in kidney transplant recipients (KTRs). However, the effect of changes in BMI after KT on these outcomes remains uncertain. The aim of this study was to investigate the effect of baseline BMI and changes in BMI on clinical outcomes in KTRs. Methods A total of 869 KTRs were enrolled from a multicenter observational cohort study from 2012 to 2015. Patients were divided into low and high BMI groups before KT based on a BMI cutoff point of 23 kg/m2. Differences in acute rejection and cardiovascular disease (CVD) between the 2 groups were analyzed. In addition, clinical outcomes across the 4 BMI groups divided by BMI change 1 year after KT were compared. Associations between BMI change and laboratory findings were also evaluated. Results Patients with a higher BMI before KT showed significantly increased CVD after KT (P = .027) compared with patients with a lower BMI. However, among the KTRs with a higher baseline BMI, only persistently higher BMI was associated with increased CVD during the follow-up period (P = .003). Patients with persistently higher BMI had significantly decreased high-density lipoprotein cholesterol and increased hemoglobin, triglyceride, and hemoglobin A1c levels. Baseline BMI and post-transplantation change in BMI were not related to acute rejection in KTRs. Conclusions BMI in the 1st year after KT as well as baseline BMI were associated with CVD in KTRs. More careful monitoring of obese KTRs who do not undergo a reduction in BMI after KT is required.

Original languageEnglish
Pages (from-to)1038-1042
Number of pages5
JournalTransplantation Proceedings
Volume49
Issue number5
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Body Mass Index
Kidney
Kidney Transplantation
Cardiovascular Diseases
Transplant Recipients
Hemoglobins
Acute Disease
HDL Cholesterol
Observational Studies
Allografts
Triglycerides
Cohort Studies

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant Recipients. / KNOW-KT Study Group.

In: Transplantation Proceedings, Vol. 49, No. 5, 01.06.2017, p. 1038-1042.

Research output: Contribution to journalArticle

@article{40ddc3818a4645b4a82f850c43780822,
title = "Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant Recipients",
abstract = "Background A higher body mass index (BMI) before kidney transplantation (KT) is associated with increased mortality and allograft loss in kidney transplant recipients (KTRs). However, the effect of changes in BMI after KT on these outcomes remains uncertain. The aim of this study was to investigate the effect of baseline BMI and changes in BMI on clinical outcomes in KTRs. Methods A total of 869 KTRs were enrolled from a multicenter observational cohort study from 2012 to 2015. Patients were divided into low and high BMI groups before KT based on a BMI cutoff point of 23 kg/m2. Differences in acute rejection and cardiovascular disease (CVD) between the 2 groups were analyzed. In addition, clinical outcomes across the 4 BMI groups divided by BMI change 1 year after KT were compared. Associations between BMI change and laboratory findings were also evaluated. Results Patients with a higher BMI before KT showed significantly increased CVD after KT (P = .027) compared with patients with a lower BMI. However, among the KTRs with a higher baseline BMI, only persistently higher BMI was associated with increased CVD during the follow-up period (P = .003). Patients with persistently higher BMI had significantly decreased high-density lipoprotein cholesterol and increased hemoglobin, triglyceride, and hemoglobin A1c levels. Baseline BMI and post-transplantation change in BMI were not related to acute rejection in KTRs. Conclusions BMI in the 1st year after KT as well as baseline BMI were associated with CVD in KTRs. More careful monitoring of obese KTRs who do not undergo a reduction in BMI after KT is required.",
author = "{KNOW-KT Study Group} and Kim, {K. Y.} and Cho, {J. H.} and Jung, {H. Y.} and Choi, {J. Y.} and Park, {S. H.} and Kim, {C. D.} and Kim, {Y. L.} and H. Ro and S. Lee and Han, {S. Y.} and Jung, {Cheol Woong} and Park, {J. B.} and Kim, {M. S.} and J. Yang and C. Ahn",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.transproceed.2017.03.049",
language = "English",
volume = "49",
pages = "1038--1042",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant Recipients

AU - KNOW-KT Study Group

AU - Kim, K. Y.

AU - Cho, J. H.

AU - Jung, H. Y.

AU - Choi, J. Y.

AU - Park, S. H.

AU - Kim, C. D.

AU - Kim, Y. L.

AU - Ro, H.

AU - Lee, S.

AU - Han, S. Y.

AU - Jung, Cheol Woong

AU - Park, J. B.

AU - Kim, M. S.

AU - Yang, J.

AU - Ahn, C.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background A higher body mass index (BMI) before kidney transplantation (KT) is associated with increased mortality and allograft loss in kidney transplant recipients (KTRs). However, the effect of changes in BMI after KT on these outcomes remains uncertain. The aim of this study was to investigate the effect of baseline BMI and changes in BMI on clinical outcomes in KTRs. Methods A total of 869 KTRs were enrolled from a multicenter observational cohort study from 2012 to 2015. Patients were divided into low and high BMI groups before KT based on a BMI cutoff point of 23 kg/m2. Differences in acute rejection and cardiovascular disease (CVD) between the 2 groups were analyzed. In addition, clinical outcomes across the 4 BMI groups divided by BMI change 1 year after KT were compared. Associations between BMI change and laboratory findings were also evaluated. Results Patients with a higher BMI before KT showed significantly increased CVD after KT (P = .027) compared with patients with a lower BMI. However, among the KTRs with a higher baseline BMI, only persistently higher BMI was associated with increased CVD during the follow-up period (P = .003). Patients with persistently higher BMI had significantly decreased high-density lipoprotein cholesterol and increased hemoglobin, triglyceride, and hemoglobin A1c levels. Baseline BMI and post-transplantation change in BMI were not related to acute rejection in KTRs. Conclusions BMI in the 1st year after KT as well as baseline BMI were associated with CVD in KTRs. More careful monitoring of obese KTRs who do not undergo a reduction in BMI after KT is required.

AB - Background A higher body mass index (BMI) before kidney transplantation (KT) is associated with increased mortality and allograft loss in kidney transplant recipients (KTRs). However, the effect of changes in BMI after KT on these outcomes remains uncertain. The aim of this study was to investigate the effect of baseline BMI and changes in BMI on clinical outcomes in KTRs. Methods A total of 869 KTRs were enrolled from a multicenter observational cohort study from 2012 to 2015. Patients were divided into low and high BMI groups before KT based on a BMI cutoff point of 23 kg/m2. Differences in acute rejection and cardiovascular disease (CVD) between the 2 groups were analyzed. In addition, clinical outcomes across the 4 BMI groups divided by BMI change 1 year after KT were compared. Associations between BMI change and laboratory findings were also evaluated. Results Patients with a higher BMI before KT showed significantly increased CVD after KT (P = .027) compared with patients with a lower BMI. However, among the KTRs with a higher baseline BMI, only persistently higher BMI was associated with increased CVD during the follow-up period (P = .003). Patients with persistently higher BMI had significantly decreased high-density lipoprotein cholesterol and increased hemoglobin, triglyceride, and hemoglobin A1c levels. Baseline BMI and post-transplantation change in BMI were not related to acute rejection in KTRs. Conclusions BMI in the 1st year after KT as well as baseline BMI were associated with CVD in KTRs. More careful monitoring of obese KTRs who do not undergo a reduction in BMI after KT is required.

UR - http://www.scopus.com/inward/record.url?scp=85020130269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020130269&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2017.03.049

DO - 10.1016/j.transproceed.2017.03.049

M3 - Article

C2 - 28583522

AN - SCOPUS:85020130269

VL - 49

SP - 1038

EP - 1042

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 5

ER -